Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4+ T cells following clinical infection

Han, WGHHelm, KPoelen, MCMOtten, HGvan Els, CACM2025-03-252025-03-2520152572849110.1016/j.clim.2015.02.009https://rivm.openrepository.com/handle/10029/648678Ex vivo peptide-MHC II tetramer analysis reveals distinct end-differentiation patterns of human pertussis-specific CD4+ T cells following clinical infectionArticleClin Immunol 2015; 157(2):205-152025-03-25